CD9-expressing B cells appear as a contributor to a favorable environment essential for the maintenance of long-term stable graft function and as a potential new predictive biomarker of bronchiolitis obliterans syndrome–free survival. Here, CD9 is linked to bronchiolitis obliterans syndrome.